2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_69965396 | 5.46 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr11_+_69964758 | 5.07 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr9_-_45204083 | 4.67 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr5_+_35056813 | 4.40 |
ENSMUST00000101298.2
ENSMUST00000114270.1 ENSMUST00000133381.1 |
Dok7
|
docking protein 7 |
chr16_+_31878810 | 4.17 |
ENSMUST00000023464.5
|
Mfi2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
chr7_-_128206346 | 4.01 |
ENSMUST00000033049.7
|
Cox6a2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr11_+_120530688 | 3.69 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr2_-_25196759 | 3.64 |
ENSMUST00000081869.6
|
Tor4a
|
torsin family 4, member A |
chr11_+_68556186 | 3.53 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr4_+_141242850 | 3.22 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr17_-_35909626 | 3.10 |
ENSMUST00000141132.1
|
Atat1
|
alpha tubulin acetyltransferase 1 |
chr2_-_129699833 | 3.07 |
ENSMUST00000028883.5
|
Pdyn
|
prodynorphin |
chr11_-_31824463 | 2.98 |
ENSMUST00000129425.1
ENSMUST00000126265.1 |
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr6_-_124769548 | 2.97 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr6_-_5256226 | 2.87 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr12_+_112620030 | 2.78 |
ENSMUST00000180015.1
ENSMUST00000021726.6 |
Adssl1
|
adenylosuccinate synthetase like 1 |
chr7_+_19083842 | 2.75 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr16_+_5007283 | 2.72 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr17_-_24689901 | 2.69 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr4_-_63154130 | 2.66 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr3_+_146117451 | 2.65 |
ENSMUST00000140214.1
|
Mcoln3
|
mucolipin 3 |
chr17_-_35910032 | 2.60 |
ENSMUST00000141662.1
ENSMUST00000056034.6 ENSMUST00000077494.6 ENSMUST00000149277.1 ENSMUST00000061052.5 |
Atat1
|
alpha tubulin acetyltransferase 1 |
chr1_-_9967932 | 2.56 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr17_-_46144156 | 2.49 |
ENSMUST00000024762.2
|
Rsph9
|
radial spoke head 9 homolog (Chlamydomonas) |
chr7_+_122219469 | 2.47 |
ENSMUST00000033152.4
|
Chp2
|
calcineurin-like EF hand protein 2 |
chr10_+_95417352 | 2.47 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr11_-_102107822 | 2.43 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr11_-_3931960 | 2.40 |
ENSMUST00000109990.1
ENSMUST00000020710.4 ENSMUST00000109989.3 ENSMUST00000109991.1 ENSMUST00000109993.2 |
Tcn2
|
transcobalamin 2 |
chr12_+_112678803 | 2.38 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr7_+_141468776 | 2.36 |
ENSMUST00000058746.5
|
Cd151
|
CD151 antigen |
chr11_-_119086221 | 2.35 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr9_-_121792478 | 2.35 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr5_+_35057059 | 2.34 |
ENSMUST00000050709.3
|
Dok7
|
docking protein 7 |
chr5_+_66968416 | 2.33 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr2_-_164356067 | 2.31 |
ENSMUST00000165980.1
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr7_-_126625676 | 2.31 |
ENSMUST00000032961.3
|
Nupr1
|
nuclear protein transcription regulator 1 |
chr6_+_90619241 | 2.30 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr16_+_30008657 | 2.27 |
ENSMUST00000181485.1
|
4632428C04Rik
|
RIKEN cDNA 4632428C04 gene |
chr4_-_138367966 | 2.25 |
ENSMUST00000030535.3
|
Cda
|
cytidine deaminase |
chr11_+_113619318 | 2.22 |
ENSMUST00000146390.2
ENSMUST00000106630.1 |
Sstr2
|
somatostatin receptor 2 |
chr4_+_128058962 | 2.21 |
ENSMUST00000184063.1
|
Csmd2
|
CUB and Sushi multiple domains 2 |
chr11_+_43528759 | 2.17 |
ENSMUST00000050574.6
|
Ccnjl
|
cyclin J-like |
chr6_+_90550789 | 2.14 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr2_-_62483637 | 2.12 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr4_+_115088708 | 2.11 |
ENSMUST00000171877.1
ENSMUST00000177647.1 ENSMUST00000106548.2 ENSMUST00000030488.2 |
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr16_+_5007306 | 2.11 |
ENSMUST00000178155.2
ENSMUST00000184256.1 ENSMUST00000185147.1 |
Smim22
|
small integral membrane protein 22 |
chr8_+_95320440 | 2.10 |
ENSMUST00000162294.1
|
Tepp
|
testis, prostate and placenta expressed |
chr2_+_152105722 | 2.10 |
ENSMUST00000099225.2
|
Srxn1
|
sulfiredoxin 1 homolog (S. cerevisiae) |
chr4_-_117872520 | 2.09 |
ENSMUST00000171052.1
ENSMUST00000166325.1 ENSMUST00000106422.2 |
Ccdc24
|
coiled-coil domain containing 24 |
chr11_+_4236411 | 2.08 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr10_+_81643797 | 2.05 |
ENSMUST00000132458.1
|
Ankrd24
|
ankyrin repeat domain 24 |
chr4_-_148500449 | 2.03 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr9_-_96437434 | 2.03 |
ENSMUST00000070500.2
|
BC043934
|
cDNA sequence BC043934 |
chr4_-_42168603 | 2.02 |
ENSMUST00000098121.3
|
Gm13305
|
predicted gene 13305 |
chr4_+_43632185 | 2.00 |
ENSMUST00000107874.2
|
Npr2
|
natriuretic peptide receptor 2 |
chr4_-_148152059 | 1.99 |
ENSMUST00000056965.5
ENSMUST00000168503.1 ENSMUST00000152098.1 |
Fbxo6
|
F-box protein 6 |
chr7_+_28440927 | 1.99 |
ENSMUST00000078845.6
|
Gmfg
|
glia maturation factor, gamma |
chr4_+_148643317 | 1.98 |
ENSMUST00000105698.2
|
Gm572
|
predicted gene 572 |
chr5_+_30281377 | 1.98 |
ENSMUST00000101448.3
|
Drc1
|
dynein regulatory complex subunit 1 |
chr15_-_66560997 | 1.96 |
ENSMUST00000048372.5
|
Tmem71
|
transmembrane protein 71 |
chr8_+_105427634 | 1.95 |
ENSMUST00000067305.6
|
Lrrc36
|
leucine rich repeat containing 36 |
chr11_-_114795888 | 1.95 |
ENSMUST00000000206.3
|
Btbd17
|
BTB (POZ) domain containing 17 |
chr4_+_41762309 | 1.95 |
ENSMUST00000108042.2
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr7_+_44225430 | 1.95 |
ENSMUST00000075162.3
|
Klk1
|
kallikrein 1 |
chr3_+_103575275 | 1.91 |
ENSMUST00000090697.4
|
Syt6
|
synaptotagmin VI |
chr1_+_90915064 | 1.90 |
ENSMUST00000027528.6
|
Mlph
|
melanophilin |
chr2_-_144331695 | 1.89 |
ENSMUST00000103171.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chr8_+_84415348 | 1.88 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr2_-_172043466 | 1.87 |
ENSMUST00000087950.3
|
Cbln4
|
cerebellin 4 precursor protein |
chr19_-_42752710 | 1.87 |
ENSMUST00000076505.3
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
chr11_-_101967005 | 1.86 |
ENSMUST00000001534.6
|
Sost
|
sclerostin |
chr7_-_46179929 | 1.85 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr8_+_123186235 | 1.84 |
ENSMUST00000019422.4
|
Dpep1
|
dipeptidase 1 (renal) |
chr10_-_77259223 | 1.83 |
ENSMUST00000105408.3
|
Gm10941
|
predicted gene 10941 |
chr10_-_75797528 | 1.82 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr5_+_30913398 | 1.82 |
ENSMUST00000031055.5
|
Emilin1
|
elastin microfibril interfacer 1 |
chr6_-_113719880 | 1.81 |
ENSMUST00000064993.5
|
Ghrl
|
ghrelin |
chr2_-_93452679 | 1.80 |
ENSMUST00000111257.1
ENSMUST00000145553.1 |
Cd82
|
CD82 antigen |
chr19_-_6996025 | 1.74 |
ENSMUST00000041686.3
ENSMUST00000180765.1 |
Nudt22
|
nudix (nucleoside diphosphate linked moiety X)-type motif 22 |
chr6_-_125494754 | 1.73 |
ENSMUST00000032492.8
|
Cd9
|
CD9 antigen |
chr13_-_3945349 | 1.73 |
ENSMUST00000058610.7
|
Ucn3
|
urocortin 3 |
chr3_+_94933041 | 1.72 |
ENSMUST00000090839.5
|
Selenbp1
|
selenium binding protein 1 |
chr17_-_47421873 | 1.71 |
ENSMUST00000073143.6
|
1700001C19Rik
|
RIKEN cDNA 1700001C19 gene |
chr10_+_87521795 | 1.70 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr17_-_26199008 | 1.68 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr5_-_120812506 | 1.67 |
ENSMUST00000117193.1
ENSMUST00000130045.1 |
Oas1c
|
2'-5' oligoadenylate synthetase 1C |
chr10_+_127866457 | 1.66 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr16_+_4639941 | 1.66 |
ENSMUST00000038770.3
|
Vasn
|
vasorin |
chr2_+_174760619 | 1.66 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr10_+_34483400 | 1.64 |
ENSMUST00000019913.7
ENSMUST00000170771.1 |
Frk
|
fyn-related kinase |
chr2_+_155381808 | 1.64 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr17_-_36168507 | 1.63 |
ENSMUST00000097335.3
ENSMUST00000173353.1 |
Gm8909
|
predicted gene 8909 |
chr9_+_87144285 | 1.62 |
ENSMUST00000113149.1
ENSMUST00000143779.1 ENSMUST00000179313.1 ENSMUST00000049457.7 ENSMUST00000153444.1 |
Mrap2
|
melanocortin 2 receptor accessory protein 2 |
chr1_+_93373874 | 1.62 |
ENSMUST00000058682.4
|
Ano7
|
anoctamin 7 |
chr17_+_33920522 | 1.62 |
ENSMUST00000172489.1
|
Tapbp
|
TAP binding protein |
chr4_+_108879063 | 1.61 |
ENSMUST00000106650.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr6_-_124733121 | 1.61 |
ENSMUST00000112484.3
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr1_-_135167606 | 1.61 |
ENSMUST00000027682.8
|
Gpr37l1
|
G protein-coupled receptor 37-like 1 |
chr2_-_164356507 | 1.61 |
ENSMUST00000109367.3
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr17_-_28560704 | 1.61 |
ENSMUST00000114785.1
ENSMUST00000025062.3 |
Clps
|
colipase, pancreatic |
chr1_-_84696182 | 1.60 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr17_+_17831298 | 1.58 |
ENSMUST00000150302.1
|
4930546H06Rik
|
RIKEN cDNA 4930546H06 gene |
chr17_-_36168532 | 1.57 |
ENSMUST00000040467.8
|
Gm8909
|
predicted gene 8909 |
chr9_+_107296843 | 1.57 |
ENSMUST00000167072.1
|
Cish
|
cytokine inducible SH2-containing protein |
chr13_-_99900645 | 1.56 |
ENSMUST00000022150.6
|
Cartpt
|
CART prepropeptide |
chr1_-_162478004 | 1.56 |
ENSMUST00000086074.5
ENSMUST00000070330.7 |
Dnm3
|
dynamin 3 |
chr3_+_105870898 | 1.56 |
ENSMUST00000010279.5
|
Adora3
|
adenosine A3 receptor |
chr7_-_31054815 | 1.55 |
ENSMUST00000071697.4
ENSMUST00000108110.3 |
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr3_+_138277489 | 1.54 |
ENSMUST00000004232.9
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr10_+_60277627 | 1.54 |
ENSMUST00000105465.1
ENSMUST00000177779.1 ENSMUST00000179238.1 ENSMUST00000004316.8 |
Psap
|
prosaposin |
chr2_+_156312299 | 1.53 |
ENSMUST00000037096.2
|
Cnbd2
|
cyclic nucleotide binding domain containing 2 |
chr11_+_115887601 | 1.51 |
ENSMUST00000167507.2
|
Myo15b
|
myosin XVB |
chr4_+_120666562 | 1.51 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr4_-_134704235 | 1.50 |
ENSMUST00000054096.6
ENSMUST00000038628.3 |
Man1c1
|
mannosidase, alpha, class 1C, member 1 |
chr18_-_34007206 | 1.50 |
ENSMUST00000025234.5
|
Epb4.1l4a
|
erythrocyte protein band 4.1-like 4a |
chr8_+_95017692 | 1.50 |
ENSMUST00000051259.8
|
Gpr97
|
G protein-coupled receptor 97 |
chr7_-_101868667 | 1.50 |
ENSMUST00000150184.1
|
Folr1
|
folate receptor 1 (adult) |
chr8_-_90908415 | 1.49 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr7_-_19796789 | 1.48 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr8_+_53511695 | 1.47 |
ENSMUST00000033920.4
|
Aga
|
aspartylglucosaminidase |
chr14_+_55853997 | 1.47 |
ENSMUST00000100529.3
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr11_+_102145530 | 1.47 |
ENSMUST00000055409.5
|
Nags
|
N-acetylglutamate synthase |
chr13_-_34345174 | 1.47 |
ENSMUST00000040336.5
|
Slc22a23
|
solute carrier family 22, member 23 |
chr16_+_17276291 | 1.47 |
ENSMUST00000164950.1
ENSMUST00000159242.1 |
Tmem191c
|
transmembrane protein 191C |
chr7_-_31055594 | 1.46 |
ENSMUST00000039909.6
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr15_+_89568322 | 1.46 |
ENSMUST00000023295.2
|
Acr
|
acrosin prepropeptide |
chr17_+_34203527 | 1.46 |
ENSMUST00000025197.5
|
Tap2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
chr4_-_134227359 | 1.46 |
ENSMUST00000105878.2
ENSMUST00000055892.3 ENSMUST00000169381.1 |
Catsper4
|
cation channel, sperm associated 4 |
chr18_+_74442551 | 1.45 |
ENSMUST00000121875.1
|
Myo5b
|
myosin VB |
chr10_+_78574492 | 1.44 |
ENSMUST00000105384.3
|
Ilvbl
|
ilvB (bacterial acetolactate synthase)-like |
chr1_+_134193432 | 1.44 |
ENSMUST00000038445.6
|
Mybph
|
myosin binding protein H |
chr11_-_31824518 | 1.43 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr16_-_94370994 | 1.43 |
ENSMUST00000113914.1
ENSMUST00000113905.1 |
Pigp
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr17_+_24696234 | 1.43 |
ENSMUST00000019464.7
|
Noxo1
|
NADPH oxidase organizer 1 |
chr8_-_123894736 | 1.43 |
ENSMUST00000034453.4
|
Acta1
|
actin, alpha 1, skeletal muscle |
chr2_-_127270032 | 1.42 |
ENSMUST00000099407.1
|
Gm10766
|
predicted gene 10766 |
chr6_+_28981490 | 1.41 |
ENSMUST00000164104.1
|
Gm3294
|
predicted gene 3294 |
chr1_-_158814469 | 1.41 |
ENSMUST00000161589.2
|
Pappa2
|
pappalysin 2 |
chr4_-_141846277 | 1.41 |
ENSMUST00000105781.1
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr9_+_46012810 | 1.41 |
ENSMUST00000126865.1
|
Sik3
|
SIK family kinase 3 |
chr2_+_91082362 | 1.41 |
ENSMUST00000169852.1
|
Spi1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr12_-_17176888 | 1.40 |
ENSMUST00000170580.1
|
Kcnf1
|
potassium voltage-gated channel, subfamily F, member 1 |
chr3_+_40708855 | 1.40 |
ENSMUST00000091184.6
|
Slc25a31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
chr2_-_25500613 | 1.40 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr19_-_3414464 | 1.39 |
ENSMUST00000025842.6
|
Gal
|
galanin |
chr7_-_100662315 | 1.39 |
ENSMUST00000151123.1
ENSMUST00000107047.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr15_+_102102926 | 1.39 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr19_+_53529100 | 1.38 |
ENSMUST00000038287.6
|
Dusp5
|
dual specificity phosphatase 5 |
chr14_+_55854115 | 1.38 |
ENSMUST00000168479.1
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr11_-_59809774 | 1.38 |
ENSMUST00000047706.2
ENSMUST00000102697.3 |
Flcn
|
folliculin |
chr13_+_119623819 | 1.38 |
ENSMUST00000099241.2
|
Ccl28
|
chemokine (C-C motif) ligand 28 |
chr4_+_120161206 | 1.38 |
ENSMUST00000030384.4
|
Edn2
|
endothelin 2 |
chr4_-_129623870 | 1.38 |
ENSMUST00000106035.1
ENSMUST00000150357.1 ENSMUST00000030586.8 |
Ccdc28b
|
coiled coil domain containing 28B |
chr7_+_49974864 | 1.38 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr5_+_137294641 | 1.37 |
ENSMUST00000052825.5
|
Ufsp1
|
UFM1-specific peptidase 1 |
chr4_-_138725262 | 1.37 |
ENSMUST00000105811.2
|
Ubxn10
|
UBX domain protein 10 |
chr7_-_44816586 | 1.37 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr3_+_96670131 | 1.36 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr15_+_31568851 | 1.35 |
ENSMUST00000070918.6
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr2_+_32608704 | 1.35 |
ENSMUST00000129165.1
|
St6galnac6
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 |
chr4_+_143349757 | 1.34 |
ENSMUST00000052458.2
|
Lrrc38
|
leucine rich repeat containing 38 |
chr2_-_25095149 | 1.33 |
ENSMUST00000044018.7
|
Noxa1
|
NADPH oxidase activator 1 |
chr7_-_127890918 | 1.33 |
ENSMUST00000121394.1
|
Prss53
|
protease, serine, 53 |
chr16_-_23890805 | 1.33 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr2_-_32775330 | 1.32 |
ENSMUST00000161089.1
ENSMUST00000066478.2 ENSMUST00000161950.1 |
Ttc16
|
tetratricopeptide repeat domain 16 |
chr11_+_87760533 | 1.32 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr14_-_34374617 | 1.32 |
ENSMUST00000023826.4
|
Sncg
|
synuclein, gamma |
chr4_+_40473130 | 1.32 |
ENSMUST00000179526.1
|
Tmem215
|
transmembrane protein 215 |
chr4_-_141825997 | 1.30 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr11_-_3931789 | 1.30 |
ENSMUST00000109992.1
ENSMUST00000109988.1 |
Tcn2
|
transcobalamin 2 |
chr2_+_25218741 | 1.30 |
ENSMUST00000028346.3
|
Fam166a
|
family with sequence similarity 166, member A |
chr9_+_107569112 | 1.29 |
ENSMUST00000010191.7
|
Hyal2
|
hyaluronoglucosaminidase 2 |
chr3_+_96576984 | 1.29 |
ENSMUST00000148290.1
|
Gm16253
|
predicted gene 16253 |
chr3_-_89093358 | 1.29 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr18_+_77185815 | 1.29 |
ENSMUST00000079618.4
|
St8sia5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
chr9_+_107340593 | 1.29 |
ENSMUST00000042581.2
|
6430571L13Rik
|
RIKEN cDNA 6430571L13 gene |
chr2_-_25501717 | 1.29 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr12_+_112808914 | 1.28 |
ENSMUST00000037014.3
ENSMUST00000177808.1 |
BC022687
|
cDNA sequence BC022687 |
chr11_+_114727384 | 1.28 |
ENSMUST00000069325.7
|
Dnaic2
|
dynein, axonemal, intermediate chain 2 |
chr9_+_54699548 | 1.28 |
ENSMUST00000070070.7
|
Dnaja4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr2_+_170731807 | 1.28 |
ENSMUST00000029075.4
|
Dok5
|
docking protein 5 |
chr5_+_30588078 | 1.28 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chrX_-_106011874 | 1.28 |
ENSMUST00000033583.7
ENSMUST00000151689.1 |
Magt1
|
magnesium transporter 1 |
chr5_-_113081579 | 1.27 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr7_+_29170204 | 1.27 |
ENSMUST00000098609.2
|
Ggn
|
gametogenetin |
chr16_+_97356721 | 1.27 |
ENSMUST00000047275.6
|
Bace2
|
beta-site APP-cleaving enzyme 2 |
chr10_+_39899304 | 1.27 |
ENSMUST00000181590.1
|
4930547M16Rik
|
RIKEN cDNA 4930547M16 gene |
chr7_+_28441026 | 1.26 |
ENSMUST00000135686.1
|
Gmfg
|
glia maturation factor, gamma |
chr17_+_25471564 | 1.26 |
ENSMUST00000025002.1
|
Tekt4
|
tektin 4 |
chr10_+_79997463 | 1.26 |
ENSMUST00000171637.1
ENSMUST00000043866.7 |
Abca7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr10_+_115817247 | 1.26 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr17_+_26933070 | 1.26 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chr5_-_137625069 | 1.25 |
ENSMUST00000031732.7
|
Fbxo24
|
F-box protein 24 |
chr7_-_101864093 | 1.25 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr13_-_51701041 | 1.25 |
ENSMUST00000110042.1
|
Gm15440
|
predicted gene 15440 |
chr3_-_89402650 | 1.25 |
ENSMUST00000168325.1
ENSMUST00000057431.5 |
Lenep
|
lens epithelial protein |
chr4_+_134864536 | 1.25 |
ENSMUST00000030627.7
|
Rhd
|
Rh blood group, D antigen |
chr10_-_81600857 | 1.25 |
ENSMUST00000151858.1
ENSMUST00000142948.1 ENSMUST00000072020.2 |
Tle6
|
transducin-like enhancer of split 6, homolog of Drosophila E(spl) |
chr19_+_42247544 | 1.25 |
ENSMUST00000122375.1
|
Golga7b
|
golgi autoantigen, golgin subfamily a, 7B |
chr11_+_87581041 | 1.25 |
ENSMUST00000018544.5
ENSMUST00000063156.4 ENSMUST00000107960.1 |
Sept4
|
septin 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.3 | 4.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.2 | 3.7 | GO:0071846 | actin filament debranching(GO:0071846) |
1.1 | 3.2 | GO:0009073 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
1.1 | 3.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
1.0 | 4.0 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 2.9 | GO:0018900 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.8 | 2.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.8 | 3.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.8 | 2.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 2.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.8 | 2.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.8 | 4.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.7 | 2.1 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.7 | 2.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.7 | 4.3 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.6 | 3.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.6 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.6 | 1.9 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.6 | 11.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.6 | 1.8 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.6 | 2.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.6 | 3.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 1.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.6 | 1.8 | GO:1905204 | cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.6 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.2 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
0.6 | 3.4 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 2.8 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.5 | 1.6 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.5 | 2.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 2.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 2.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 2.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 5.5 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.5 | 1.5 | GO:0046968 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.5 | 1.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 1.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 1.9 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.5 | 1.4 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.5 | 3.2 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 3.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 2.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.8 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 1.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.6 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.4 | 1.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 4.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 2.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 1.3 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.4 | 5.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 1.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.4 | 1.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.4 | 3.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 5.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.4 | 0.8 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.4 | 4.0 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
0.4 | 1.2 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.4 | 1.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 4.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.4 | 1.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.4 | 3.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.1 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 1.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.4 | 4.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 1.9 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.4 | 5.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.4 | 1.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.4 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 0.4 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
0.4 | 3.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 2.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 1.0 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.3 | 2.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 0.7 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.3 | 1.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 1.0 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.3 | 1.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 1.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.0 | GO:0033189 | response to vitamin A(GO:0033189) |
0.3 | 1.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.3 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 1.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 1.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 2.6 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 0.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 0.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.3 | 0.9 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.3 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 0.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.3 | 1.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 0.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.3 | 3.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 1.5 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.3 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 2.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 1.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 0.6 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.3 | 0.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 0.9 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 1.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 0.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 2.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.3 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 5.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 2.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.5 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.8 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 0.8 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.3 | 1.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.0 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 1.0 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.7 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.2 | 1.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 1.2 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 1.9 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.2 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.2 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.7 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.2 | 0.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 2.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.6 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.2 | 2.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 3.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.5 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
0.2 | 0.7 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.2 | 0.5 | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 1.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 2.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 1.1 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 0.7 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 0.9 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.9 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 1.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 2.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 1.9 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.9 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.6 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 3.6 | GO:0051645 | Golgi localization(GO:0051645) |
0.2 | 0.4 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
0.2 | 0.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.0 | GO:1990839 | response to endothelin(GO:1990839) |
0.2 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 1.0 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.6 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.2 | 1.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.2 | 0.6 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.2 | 1.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 1.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 1.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.6 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 1.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 0.8 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 0.6 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.2 | 0.8 | GO:0072039 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.2 | 0.6 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.2 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 2.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.2 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.2 | 0.6 | GO:0002879 | cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 1.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.7 | GO:0010286 | heat acclimation(GO:0010286) |
0.2 | 0.7 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.4 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.7 | GO:0046882 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.2 | 0.9 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.7 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 0.5 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 1.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 1.5 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.2 | 0.3 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.2 | 2.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 1.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 2.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.2 | 0.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.5 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.7 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.5 | GO:0071910 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.5 | GO:0015881 | creatine transport(GO:0015881) |
0.2 | 0.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.2 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.5 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 1.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.5 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.2 | 0.5 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 1.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 1.5 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.2 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.9 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 0.4 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.1 | 1.8 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.1 | 1.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 1.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.4 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 1.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 1.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 2.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 2.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 2.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:0009744 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 1.0 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 1.1 | GO:1900244 | regulation of synaptic vesicle endocytosis(GO:1900242) positive regulation of synaptic vesicle endocytosis(GO:1900244) |
0.1 | 1.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 5.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.4 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.5 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.5 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 1.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 3.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.1 | 0.4 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.1 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.1 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 1.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 3.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.5 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.1 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.6 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.8 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 1.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 3.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.7 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.3 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.1 | 0.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 3.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0070375 | response to laminar fluid shear stress(GO:0034616) ERK5 cascade(GO:0070375) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.1 | 0.8 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 1.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.7 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 1.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 2.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 4.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.0 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 1.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 1.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 1.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 1.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.5 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0032379 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.1 | 0.3 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 2.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.7 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 1.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 2.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 2.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.3 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.1 | 0.4 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 2.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.4 | GO:0007620 | insemination(GO:0007320) copulation(GO:0007620) |
0.1 | 1.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.6 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) response to sodium arsenite(GO:1903935) |
0.1 | 0.2 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.1 | 0.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.7 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 3.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.3 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.5 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 1.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.6 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 1.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 3.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.1 | 1.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.3 | GO:0015872 | dopamine transport(GO:0015872) |
0.1 | 0.6 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0033379 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.1 | 2.0 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.8 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:0072708 | response to sorbitol(GO:0072708) |
0.1 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 2.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.3 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0033634 | positive regulation of integrin activation(GO:0033625) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.2 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.4 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:1904430 | negative regulation of mitotic recombination(GO:0045950) negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 3.8 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 1.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.1 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0031579 | membrane raft organization(GO:0031579) |
0.1 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 1.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 1.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.6 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.4 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.4 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.6 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.3 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 2.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.2 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.0 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.0 | 0.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.6 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 1.0 | GO:0097009 | energy homeostasis(GO:0097009) |
0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.0 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.3 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 1.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 1.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.9 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.1 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.2 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
0.0 | 0.1 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.3 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 1.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 1.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 1.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 2.2 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.3 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.9 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.5 | GO:0001709 | cell fate determination(GO:0001709) |
0.0 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 1.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.1 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.0 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 1.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:1905153 | regulation of phagocytosis, engulfment(GO:0060099) regulation of membrane invagination(GO:1905153) |
0.0 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.0 | 0.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.4 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0009446 | spermidine biosynthetic process(GO:0008295) putrescine biosynthetic process(GO:0009446) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0098711 | iron ion import into cell(GO:0097459) iron ion import across plasma membrane(GO:0098711) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.0 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.2 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.0 | GO:0046416 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) D-serine metabolic process(GO:0070178) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.4 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0035553 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 2.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 4.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 4.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.5 | 3.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 11.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.4 | 4.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 0.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 4.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 2.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 3.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.4 | 1.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.3 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 2.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.3 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 2.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.0 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.3 | 0.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.7 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.2 | 1.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 1.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.2 | 1.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.2 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 1.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.1 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 2.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 5.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 3.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 4.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 1.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 3.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 4.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 3.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 2.4 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
0.2 | 2.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 2.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 5.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 2.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 1.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 3.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 2.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.9 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 4.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 0.9 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 1.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.7 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 5.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 1.0 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 3.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 1.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.3 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 2.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.4 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 3.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.4 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 6.4 | GO:0005930 | axoneme(GO:0005930) |
0.1 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 5.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.7 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 1.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.8 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 8.2 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 51.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 3.4 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 8.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 10.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 4.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 2.9 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.0 | 2.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 5.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 2.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.7 | 2.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.6 | 3.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 3.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.8 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.6 | 0.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.6 | 1.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.6 | 3.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 12.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 1.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 1.6 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.5 | 1.5 | GO:0046911 | metal chelating activity(GO:0046911) |
0.5 | 5.9 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 1.9 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.5 | 1.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 1.4 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.5 | 1.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.4 | 1.8 | GO:0070976 | TIR domain binding(GO:0070976) |
0.4 | 4.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 3.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.4 | 2.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 2.5 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 1.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 2.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 3.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 1.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.4 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.0 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.3 | 2.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.3 | 2.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 1.3 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 1.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 1.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.3 | 1.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.3 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 1.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 3.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.3 | 3.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 1.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 1.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 4.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 1.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.3 | 2.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.8 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.2 | 2.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 3.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 1.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 2.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 2.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 1.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.9 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.2 | 0.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 0.9 | GO:0032029 | myosin tail binding(GO:0032029) |
0.2 | 0.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 1.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 1.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 0.6 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 0.6 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 0.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.0 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 0.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 2.6 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 2.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 1.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.6 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.2 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 3.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 5.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 0.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.7 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 4.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.2 | 2.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 4.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.5 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 4.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 2.0 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 2.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 8.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 0.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.1 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 7.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 2.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.4 | GO:0005302 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 3.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 4.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.4 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 3.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 4.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 4.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) starch binding(GO:2001070) |
0.1 | 18.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.1 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.7 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.3 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.9 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.6 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.3 | GO:0047237 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 1.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 4.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 1.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 3.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.9 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 3.8 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.7 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 3.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.5 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.1 | 0.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 3.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0030977 | taurine binding(GO:0030977) |
0.1 | 0.1 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 2.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 3.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.6 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 2.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 2.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 1.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 1.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.0 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 3.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 3.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 4.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 1.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.0 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 1.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.3 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 1.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 6.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 21.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.1 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 5.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 3.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 8.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 7.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 6.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 17.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 7.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 2.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 3.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 0.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 5.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 3.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 3.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.6 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 3.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 3.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 2.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 17.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 4.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 2.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 2.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 6.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.7 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 1.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 2.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 2.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 2.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.9 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 2.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |